| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |